Dolor vs. Inflamación

1. Urgelles LA. Dolor nociceptivo vs. neuropático: Medicina Fisiológica de Regulación (FMR) nuevo enfoque para su control. Rev Mexicana de Algología 2008;5:10:17-22.
2. Urgelles LA. Nociceptive Pain vs. Neuropathic Pain - A new classification for Pain Control. Physiological Regulating Medicine, Italy 2008;1:39-42.
3. Urgelles LA. La clínica del dolor en oncología: un objetivo inmediato. Rev Cub Oncol 1989; 5:1-2:51-64.
4. Urgelles LA. Dolor y Cáncer. Rev. Selecta Médica. Colombia 1998;9:3:25-26.
5. Ventafrida V, et al. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:851-856.
6. Ventafrida V. Continuing care: a major issue in cancer pain management. Pain 1989;36:137-143.
7. Russell KP. Three-step analgesic for management of cancer pain. Medicine News 2007;5:6:81-91.
8. Milani L. Inflammation and Physiological Regulating Medicine: New ideas and innovative medical products. PRM, 2007;1:19-27.
9. Lester, A.D.: Chemokines-chemotactic molecules that mediate inflammation. Journal of Medicine. New England.1998;338:436-445. (Citado por 8-Milani, L.)
10. Bianchi I. Th1/Th2 Balance Diluted and Potentized Cytokines; The Role of Physiological Regulating Medicine in Inmunoregulation. Loyola University. Chicago. USA. Nov. 2007.
11. Brynskov J, et al. Increased concentrations of interleukin-1 beta, interleukin-2 and soluble interlaukin-2 receptor in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33:1:55-58.
12. Urgelles LA. Nimesulida: nuevo AINE en el alivio del dolor asociado al cáncer /Nimesulide: a new nsaids asociate in the mitigation of cancer pain. Clín Méd HCC Venezuela 1996; 1:2 :78-82.
13. Urgelles LA and LF Cifuentes: Celebrex (celecoxib). Analgésico del milenio. J Clínica en Odontología. Venezuela. 2002; 17(2): 105-109.
14. Chandrasekharan NV et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99 (21):13926-31.
15. Botting R. COX-1 and COX-3 inhibitors. Thrombosis Research 2003; 110:5-6:269-272.
16. Linde L et al. Are the clinical effects of homeopathy placebo effect? A metaanalysis of placebo controlled trials. Lancet. 1997; 350:834-843. (Citado por 17-Ricottini, L)
17. Ricottini L. From homeopathy to physiological regulating medicine: highlights. Physiological Regulating Medicine, Italy 2008; 1: 31-35.
18. Pennec JP and M Aubin: Effect of Aconitum and Veratrum on the isolated perfused heart of commun eel (Anguilla). Comp Biochem physiol 1984: 776:367-369. (Citado por 8-Milani, L.).
19. Stumpf WE. J. Pharmacol Toxicol Methods 2005; 51:1;25. (Citado por 8-Milani, L.).
20. Kuritzky L and G Samraj: Current treatments in the management of diabetic peripheral neuropathic pain. Pain Medicine News 2007; 5: 6: 11-20.
21. Gupta K. Prevalence, diagnosis and management of fibromyalgia. Medicine News 2007; 5: 6: 32-36.
22. Milani L. Pain Management. Guna Injectable Ampoules. Guna S.p.a., Italy, 2007. www.gunainc.com
23. Urgelles LA. Medicina Fisiológica de Regulación en el manejo del Dolor. 3er. Tour Mexico. 2008.
24. Milani L. Homeomesotherapy for pain management in primary chronic coxarthrosis with a homeopathic injectable formulation. Physiological Regulating Medicine 2006; 1: 9-18.
25. Milani L. Innovative Treatment concepts in Traumatology, Fibromyalgia, Pain and Sport Medicine with PRM. Syllabus. 3rd US National Tour. November 2007.